TY - JOUR
T1 - Characteristics of healthy vascular ageing in pooled population-based cohort studies
T2 - The global metabolic syndrome and artery research consortium
AU - Metabolic syndrome, Arteries REsearch (MARE) Consortium
AU - Nilsson, Peter M.
AU - Laurent, Stephane
AU - Cunha, Pedro G.
AU - Olsen, Michael H.
AU - Rietzschel, Ernst
AU - Franco, Oscar H.
AU - Ryliškyte, Ligita
AU - Strazhesko, Irina
AU - Vlachopoulos, Charalambos
AU - Chen, Chen Huan
AU - Boutouyrie, Pierre
AU - Cucca, Francesco
AU - Lakatta, Edward G.
AU - Scuteri, Angelo
N1 - Funding Information:
The Guimarães Study was funded by the Life and Health Research Institute, Medical School, Minho University, Portugal
Funding Information:
The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research; the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Heart Foundation; the Ministry of Education, Culture and Science; the Ministry of Health Welfare and Sports; the European Commission; and the Municipality of Rotterdam.
Funding Information:
The SardiNIA team was supported by Contract NO1-AG-1–2109 from the NIA. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging (USA).
Funding Information:
The Malmoe Diet Cancer – Cardiovascular Study was supported by grants from the Swedish Research Council (K2008-65X-20752-01-3, K2011-65X-20752-04-6), the Lund-ströms Foundation, the Swedish Heart-Lung Foundation (2010-0244; 2013-0249) and ALF government grants (Dnr: 2012/1789).
Funding Information:
The Kingmen Aging Study was supported, in part, by a grant from the National Science Council (NSC 99-2314-B-010-034-MY3), an intramural grant from the Taipei Veterans General Hospital (grant V102C-119), Research and Development contract NO1-AG-1–2118, and the Intramural Research Program of the National Institute on Aging, National Institutes of Health.
Funding Information:
Financial support: The Asklepios Study is supported by the Fund for Scientific Research – Flanders (FWO research grants G042703 and G083810N).
Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Objective: Arterial ageing is characterized by increasing arterial stiffness as measured by pulse wave velocity (PWV) This process is enhanced in participants with early vascular ageing (EVA), but slowed in participants with healthy vascular ageing (HVA). We aimed to describe characteristics of EVA and HVA in a transcontinental study including 11 cohorts. Methods: In all, 18490 participants from the global MAR Consortium, free of cardiovascular disease, participated with data on PWV and cardiometabolic risk factors. We defined HVA as the lowest 10% and EVA as the highest 10% of the standardized PWV distribution, adjusted for age intervals. HVA individuals were compared with the 90% of non-HVA individuals with ANCOVA, adjusted for age, sex and hypertension. Results: The 1723 HVA participants were at the same age as the rest of the population, more likely women (59.4 vs 57.0%), and with significantly lower levels of established cardiovascular risk factors (blood pressure, lipids, glucose). Similarly, the prevalence rate of obesity, diabetes mellitus, hypertension and the metabolic syndrome was lower in the HVA participants. In the presence of similar levels of cardiovascular risk factors, HVA participants in the 50-64 years of age group presented lower PWV 5.8 (SD 0.5) vs. 7.4 (1.4) m/s (P<0.0001) than control individuals in the 35-49 years of age group, corresponding to an estimated difference in chronological age of 14 years. Conclusion: Participants with healthy vascular ageing (HVA), belonging to the lowest end of the PWV distribution, are in general characterized by an up to 14 years estimated younger biological (vascular) age than those with higher PWV values, and have lower levels of risk factors.
AB - Objective: Arterial ageing is characterized by increasing arterial stiffness as measured by pulse wave velocity (PWV) This process is enhanced in participants with early vascular ageing (EVA), but slowed in participants with healthy vascular ageing (HVA). We aimed to describe characteristics of EVA and HVA in a transcontinental study including 11 cohorts. Methods: In all, 18490 participants from the global MAR Consortium, free of cardiovascular disease, participated with data on PWV and cardiometabolic risk factors. We defined HVA as the lowest 10% and EVA as the highest 10% of the standardized PWV distribution, adjusted for age intervals. HVA individuals were compared with the 90% of non-HVA individuals with ANCOVA, adjusted for age, sex and hypertension. Results: The 1723 HVA participants were at the same age as the rest of the population, more likely women (59.4 vs 57.0%), and with significantly lower levels of established cardiovascular risk factors (blood pressure, lipids, glucose). Similarly, the prevalence rate of obesity, diabetes mellitus, hypertension and the metabolic syndrome was lower in the HVA participants. In the presence of similar levels of cardiovascular risk factors, HVA participants in the 50-64 years of age group presented lower PWV 5.8 (SD 0.5) vs. 7.4 (1.4) m/s (P<0.0001) than control individuals in the 35-49 years of age group, corresponding to an estimated difference in chronological age of 14 years. Conclusion: Participants with healthy vascular ageing (HVA), belonging to the lowest end of the PWV distribution, are in general characterized by an up to 14 years estimated younger biological (vascular) age than those with higher PWV values, and have lower levels of risk factors.
KW - Age
KW - Arterial
KW - Blood pressure
KW - Cohort
KW - Epidemiology
KW - Health
KW - Metabolic syndrome
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=85055840111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055840111&partnerID=8YFLogxK
U2 - 10.1097/HJH.0000000000001824
DO - 10.1097/HJH.0000000000001824
M3 - Article
C2 - 30063641
AN - SCOPUS:85055840111
SN - 0263-6352
VL - 36
SP - 2340
EP - 2349
JO - Journal of hypertension
JF - Journal of hypertension
IS - 12
ER -